This market research report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology, neurology, cardiology and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging. The research study provides global market analysis for biomarkers by the above disease areas and also by prominent biomarker discovery technologies including imaging, genomics, proteomics, metabolomics, bioinformatics and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology. Though the research report mentions about non-medical applications of biomarkers, the study emphasizes only on the medical applications. The study includes estimates and projections for the total global, biomarkers market. The market covered for genomics, proteomics and bioinformatics pertains only to biomarker discovery applications.

Download the short sample report.

Download the table of contents in PDF format.

Biomarkers discovery is fast gaining importance, especially in the field of medical research. Latest innovations in the area of transcriptomics, proteomics and metabolomics are driving the trend. Global biomarkers market is projected to reach about US$ 22.7 billion by 2012, with the United States retaining its dominance. Asia Pacific is the most vibrant region while Europe has some of the leading biomarkers companies. Cardiology is projected to be the fastest growing therapeutic area of biomarkers during the analysis period 2005-2012 with a CAGR of 23.01% followed by Neurology and Oncology. Bioinformatics is projected to be the fastest growing discovery technology for biomarkers for the analysis period 2005-2010 with a CAGR of 23.46% followed by Genomics and Metabolomics.

The latest trends and advancements in biotechnology have offered enormous expansion of genomics, proteomics and metabolomics fields by enabling cost effective DNA sequencing, mass spectroscopic antibody analyzing and evaluation of metabolic patterns of health by using NMR techniques. The introduction of these techniques to the field of biotechnology has led to the generation of incredible quantity of innovative biological and pharmaceutical information. The advancements in the field of information technology have enabled storing and retrieving of large quantities of data with minimal expenditure. The entry of mathematical applications into the field of biomarkers has helped in devising numerous mathematical and statistical equations to evaluate the stored medical and pharmaceutical data to provide error free biomarker development.

- Affibody AB (Sweden)
- Affymetrix, Inc. (USA)
- Agilent Technologies, Inc. (USA)
- Applied Biosystems Group (USA)
- AVIVA Biosciences Corporation (USA)
- Bayer AG (Germany)
- Beckman Coulter, Inc. (USA)
- BG Medicine, Inc. (USA)
- Biacore International AB (Sweden)
- BioForce Nanosciences, Inc. (USA)
- BioMarker Pharmaceuticals, Inc. (USA)
- BioSense Laboratories AS (Norway)
- Biotrin International (Ireland)
- BRAHMS AG (Germany)
- Bristol Myers Squibb Co. (USA)
- Bruker Daltonics, Inc. (USA)
- Calibrant Biosystems, Inc. (USA)
- Caprion Pharmaceuticals, Inc. (Canada)
- Celera Genomics Group (USA)
- Ciphergen Biosystems, Inc. (USA)
- Compugen Ltd. (Israel)
- Correlogic Systems, Inc. (USA)
- Dako A/S (Denmark)
- Diagnostics Products Corporation (USA)
- DxS Ltd. (UK)
- Eli Lilly and Co. (USA)
- Epigenomics AG (Germany)
- Fujirebio Diagnostics, Inc. (USA)
- GE Healthcare (UK)
- Gene Logic, Inc. (USA)
- Genedata AG (Switzerland)
- Genego, Inc. (USA)
- GeneNews Ltd. (Canada)
- Human Metabolome Technologies, Inc. (Japan)
- IBEX Technologies, Inc. (Canada)
- Iconix Biosciences, Inc. (USA)
- Large Scale Biology Corporation (USA)
- MDS Pharma Services (UK)
- Metabolon, Inc. (USA)
- Monogram Biosciences, Inc. (USA)
- Nonlinear Dynamics Ltd. (UK)
- Novartis AG (Switzerland)
- Oy Jurilab Ltd. (Finland)
- Pathwork Diagnostics (USA)
- PerkinElmer, Inc. (USA)
- Pfizer, Inc. (USA)
- Proteome Sciences plc (UK)
- Proteome Systems Ltd. (Australia)
- Soiken, Inc. (Japan)
- SomaLogic, Inc. (USA)
- Thermo Fisher Scientific, Inc. (USA)
- TheRyte Ltd. (UK)
- Triesta Sciences, Inc. (India)
- Upstream Biosciences, Inc. (Canada)
- Vermillion, Inc. (USA)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Report synopsis summarizes the global Biomarkers market by Discovery Technologies - Imaging, Genomics, Proteomics, Metabolomics, and Bioinformatics and Therapeutic Areas - Oncology, Cardiology, and Neurology. It also includes profiles of major companies and market analysis of Biomarkers Discovery Technologies and Therapeutic Areas by geographic region including North America, Europe, and Asia-Pacific. Corresponding market values in US$ (2005 through 2012) provided with graphs and charts.	$1275
III	Product / Technology Research	This chapter gives an insight into various types of Biomarkers including definitions, segmentation and applications. It provides market values in US$ (for the period 2005 through 2012) for Biomarker Identification technologies. Details of the role of biomarkers in various diseases, respective market values and treatments and effects are included. It also includes product trends and potential opportunities of biomarkers in drug discovery and development.	$850
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for Biomarkers Technologies. It includes global market analysis (in US$) by geographic region; analysis of each region by both technology and product segment; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc.	$1400
V	Corporate Directory	This chapter provides a region-wise list of 402 companies, CROs and academic institutions that are engaged in Biomarker products and/or services.	$300